Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Surv Ophthalmol ; 68(3): 539-555, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-35970232

RESUMEN

Every year millions of children are exposed to general anesthesia while undergoing surgical and diagnostic procedures. In the field of ophthalmology, 44,000 children are exposed to general anesthesia annually for strabismus surgery alone. While it is clear that general anesthesia is necessary for sedation and pain minimization during surgical procedures, the possibility of neurotoxic impairments from its exposure is of concern. In animals there is strong evidence linking early anesthesia exposure to abnormal neural development. but in humans the effects of anesthesia are debated. In humans many aspects of vision develop within the first year of life, making the visual system vulnerable to early adverse experiences and potentially vulnerable to early exposure to general anesthesia. We attempt to address whether the visual system is affected by early postnatal exposure to general anesthesia. We first summarize key mechanisms that could account for the neurotoxic effects of general anesthesia on the developing brain and review existing literature on the effects of early anesthesia exposure on the visual system in both animals and humans and on neurocognitive development in humans. Finally, we conclude by proposing future directions for research that could address unanswered questions regarding the impact of general anesthesia on visual development.


Asunto(s)
Anestesia General , Encéfalo , Niño , Animales , Humanos , Anestesia General/efectos adversos
2.
Ophthalmic Genet ; 43(5): 685-688, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-35672901

RESUMEN

Harboyan syndrome is a rare autosomal recessive disorder characterised by congenital hereditary endothelial dystrophy (CHED), with a later onset of sensorineural hearing loss, due to pathogenic variants in the SLC4A11 gene. Congenital cytomegalovirus (CMV) may also manifest with sensorineural hearing loss and visual impairment. We present a case of a 4-year-old girl, diagnosed at birth with a congenital CMV infection, but careful phenotyping and genetic testing permitted a more likely diagnosis of Harboyan syndrome.


Asunto(s)
Distrofias Hereditarias de la Córnea , Infecciones por Citomegalovirus , Pérdida Auditiva Sensorineural , Proteínas de Transporte de Anión/genética , Antiportadores/genética , Preescolar , Distrofias Hereditarias de la Córnea/genética , Infecciones por Citomegalovirus/diagnóstico , Errores Diagnósticos , Femenino , Pérdida Auditiva Sensorineural/diagnóstico , Pérdida Auditiva Sensorineural/genética , Humanos , Recién Nacido
3.
J AAPOS ; 26(4): 216-218, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-35659977

RESUMEN

We present the findings of 2 children with neonatal hypoxic ischemic encephalopathy (HIE), who demonstrated ocular neovascularization at birth. While the cerebral effects of HIE have been well described, ocular effects have not. Our cases, combined with recent published laboratory research, demonstrate that significant ocular effects may accompany HIE.


Asunto(s)
Hipoxia-Isquemia Encefálica , Niño , Humanos , Hipoxia-Isquemia Encefálica/complicaciones , Hipoxia-Isquemia Encefálica/diagnóstico , Recién Nacido
7.
J AAPOS ; 22(3): 239-240, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29604343

RESUMEN

Congenital toxoplasmosis (CT) is a parasitic disease that causes serious fetal and neonatal harm or death. In countries that do not have antenatal screening programs, the initiation of CT treatment relies on a postnatal diagnosis. Until recently, diagnosis was based on clinical signs and immunoglobulin seropositivity, which is fraught with difficulty. In these cases, diagnosis was often delayed or treatment, which carries risk, started empirically. We highlight the use of polymerase chain reaction to diagnose a case of congenital toxoplasmosis, allowing early treatment and justifying the treatment burden.


Asunto(s)
ADN Protozoario/sangre , ADN Protozoario/líquido cefalorraquídeo , Reacción en Cadena de la Polimerasa/métodos , Toxoplasmosis Congénita/diagnóstico , Toxoplasmosis Ocular/diagnóstico , Antiprotozoarios/uso terapéutico , Quimioterapia Combinada , Diagnóstico Precoz , Electroencefalografía , Humanos , Lactante , Leucovorina/uso terapéutico , Imagen por Resonancia Magnética , Masculino , Pirimetamina/uso terapéutico , Punción Espinal , Sulfadiazina/uso terapéutico , Tomografía Computarizada por Rayos X , Toxoplasmosis Congénita/sangre , Toxoplasmosis Congénita/líquido cefalorraquídeo , Toxoplasmosis Congénita/tratamiento farmacológico , Toxoplasmosis Ocular/sangre , Toxoplasmosis Ocular/líquido cefalorraquídeo , Toxoplasmosis Ocular/tratamiento farmacológico , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA